skip to main content
Show Results with:

Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE)

Drake, Marcus J. et al.

International journal of clinical practice. Volume 71:Issue 5 (2017); pp n/a-n/a -- John Wiley & Sons Inc

Online access

Searching Remote Databases, Please Wait